This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback
Trial record 9 of 590 for:    "Colonic Neoplasms"

Aerobic Capacity and Body Composition in Colon Cancer Patients

This study has been completed.
Information provided by (Responsible Party):
AHS Cancer Control Alberta Identifier:
First received: May 7, 2007
Last updated: February 24, 2016
Last verified: April 2012
Recent studies have shown that survival after a colorectal cancer diagnosis may be affected by a person's activity level and body size. This research says that for colorectal cancer patients, the less active and more obese they are, the more likely they are to have a cancer recurrence or die from their cancer. Chemotherapy has been shown to reduce activity levels, fitness, and body size in some cancer patients. However, it is not known how chemotherapy specific for colon cancer patients affects their activity levels, fitness, and body size. The main goal of our study will be to look at how chemotherapy treatments affect the fitness, activity levels, and body size in colon cancer patients. In order to do this, we will measure these variables before chemotherapy treatments, and at 1 and 6 months following the end of treatment. Our results will show how chemotherapy affects fitness, activity levels, and body size in colon cancer patients and provide data to help in designing an exercise intervention specifically for colon cancer survivors.

Colonic Neoplasms

Study Type: Observational
Study Design: Observational Model: Case-Only
Official Title: Changes in Aerobic Capacity and Body Composition in Colon Cancer Patients Receiving Chemotherapy

Further study details as provided by AHS Cancer Control Alberta:

Enrollment: 40
Study Start Date: October 2007
Study Completion Date: October 2009
Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
community sample

Inclusion Criteria:

  • histologically confirmed colon cancer (Stage III and those Stage II patients deemed high-risk
  • approval of the treating oncologist
  • scheduled to received chemotherapy
  • able to understand and provide written informed consent in English
  • 18+ years of age
  • no uncontrolled co-morbidities (including hypertension, cardiac illness, psychiatric condition, etc.)
  • negative ECG as assessed during maximal graded exercise test

Exclusion Criteria:

  • metastatic or recurrent colon cancer patients
  • pregnancy
  • any uncontrolled medical condition that would be a contraindication to exercise (assessed by treating oncologist)
  • unwilling to attend, travel to or participate in the assessments at all 3 time points

In addition, 10 patients meeting all of the eligibility criteria who are not scheduled to receive chemotherapy will also be recruited to the study to serve as "surgery only" controls.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00470782

Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Sponsors and Collaborators
AHS Cancer Control Alberta
Principal Investigator: Kerry Courneya, PhD University of Alberta
  More Information

Responsible Party: AHS Cancer Control Alberta Identifier: NCT00470782     History of Changes
Other Study ID Numbers: GI-5-0064 / ethics 23429
Study First Received: May 7, 2007
Last Updated: February 24, 2016

Keywords provided by AHS Cancer Control Alberta:
colonic neoplasms
body composition

Additional relevant MeSH terms:
Colonic Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases processed this record on September 21, 2017